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Certificate of Confidentiality
Guideline
Sarah Fowler-Dixon, PhD
HRPO Committee Breakfast
April 25, 2007

What is a CoC?
• Certificates of Confidentiality are issued by
the National Institutes of Health (NIH) or
the Food Drug Administration (FDA) to
protect identifiable research
information from forced disclosure
(subpoena).

CoC is ineffective when:
1. the information is already in the medical record.
2. no sensitive information is being collected.
3. when disclosure is mandated by state or federal law.
Examples include: suspected child abuse, threat of harm
to self or others, reportable communicable diseases,
FDA or DHHS audit or program evaluation
4. the participant discloses the information to his/her
insurance company, primary care provider or other
clinician, any other voluntary disclosure, etc.
5. Data maintained outside the U.S.

The Future
• HRPO will request a CoC when it is
thought that the study design and
University research protections are not
sufficient.
• Investigators, or the sponsor, are always
free to obtain a CoC if they wish to have
one for their study.

Examples of University Research
Protections
• All subpoenas are fought whether or not a
CoC is in place
• HIPAA regulations
• WU Confidentiality Guidelines found at
http://hrpo.wustl.edu under Guidelines

Examples of Other Protections not
utilizing a CoC
• Keep information as de-identified as much as possible.
Examples include: anonymizing or coding data without
the use of master lists, or with master lists and use of the
“honest broker” mechanism.
• Use of confidentiality agreements in some research
teams/studies.
• Keep information in locked locations, behind two keys,
with limited access
• Maintain clinical records separate from research records

Examples of Protections not
utilizing a CoC
• Obtain permission for gathering the sensitive
information by putting what is being collected and
shared explicitly in the consent document under
Participation and allowing the participant to read
and sign the consent document prior to gathering
the sensitive information.
• Avoid collecting sensitive information
• Educate your research participants on how to
protect their confidentiality.

Does it require a CoC?
• Longitudinal study using a small research
population. Questions are being asked
concerning sexual preferences, illicit drug
use, and familial history of abuse. The PI
may wish to obtain a CoC to provide
added protections to this small population.

Does it require a CoC?
• A study screens for substance abuse as
indicators of potential non-compliance with
prescribed medications and disease relapse.
The investigator asks the participant for
permission to share relevant clinical information
with treatment providers (e.g. if the clinical
information has the potential to benefit the
participant medically). Thus, the information
enters the medical record. A CoC would afford
no protections.

Does it require a CoC?
• The study uses only clinically derived
information. All information is obtained
from the medical record. The CoC affords
no protections.

Does it require a CoC?
• A short term study collects sensitive
information that may damage the
participant's reputation, livelihood or wellbeing if the information were divulged in a
court of law. Information is coded and the
master list is kept in a separately locked
cabinet. Only the PI and study coordinator
have access to the master list. Depending
on the nature of the questions, the
protections in place could be sufficient.

Does it require a CoC?
• A study uses an investigational drug. The
sponsor has not applied for a CoC as all
screening information is part of the
medical history and therefore in the clinical
record. A CoC would not afford any
additional protections.

Does it require a CoC?
• A study asks questions regarding illegal
activities within a family. Questions are
worded so that members of the family may
or may not be readily identified. In either
case, the answers would be regarded
legally as hearsay and the answers to the
questions are recorded in a completely
anonymous fashion. The CoC would not
afford any additional protections.

Does it require a CoC?
• A study will use drug screening and
sensitive questions. Both are outlined in
the consent document together with a
statement of risks and will only occur once
the participant has agreed to participate.
The CoC is not necessary.

Does it require a CoC?
• Information regarding screen failures will be
sent to the sponsor with identifiers. The
information collected is sensitive such as
HIV or drug testing results. If this
information is already known and in the
medical record, a CoC is not necessary. If
this information is not already known then
we need to consider how identifiable and
sensitive the information is that is being
sent.

Does it require a CoC?
• A study is using classifications found in the
the DSM IV. The need for a CoC would
depend on the nature of the study,
protections afforded in the study and the
population being targeted. A CoC would
not automatically be required because a
certain standardized instrument is being
used.

